- Home
- ZBH vs SNN Comparison
ZBH vs SNN Comparison
Compare ZBH & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZBH | SNN |
|---|---|---|
| Founded | 1927 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Industrial Specialties | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 14.3B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZBH | SNN |
|---|---|---|
| Price | $87.97 | $30.08 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 21 | 2 |
| Target Price | ★ $101.00 | $36.25 |
| AVG Volume (30 Days) | ★ 1.8M | 1.1M |
| Earning Date | 04-28-2026 | 03-16-2026 |
| Dividend Yield | 1.20% | ★ 2.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $8,231,500,000.00 | N/A |
| Revenue This Year | $4.96 | $8.58 |
| Revenue Next Year | $3.76 | $5.60 |
| P/E Ratio | $72.28 | ★ $64.97 |
| Revenue Growth | ★ 7.20 | N/A |
| 52 Week Low | $79.12 | $29.08 |
| 52 Week High | $108.29 | $38.79 |
Technical Indicators
Market Signals| Indicator | ZBH | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 44.71 |
| Support Level | $85.50 | $29.10 |
| Resistance Level | $90.50 | $31.28 |
| Average True Range (ATR) | 2.12 | 0.49 |
| MACD | 0.33 | 0.03 |
| Stochastic Oscillator | 71.51 | 42.11 |
Price Performance
Historical ComparisonAbout ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.